back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-12 10:40 Tx date 2023-11-02 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
57 - Exercise of rights
|
$65,000
+20,000 vol $3.25 each |
1,004,231 | |
| Filed 2024-03-12 10:39 Tx date 2023-11-02 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-20,000 vol |
227,842 | |
| Filed 2024-03-12 10:21 Tx date 2020-09-02 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
LLC Units convertible into SV Shares Cresco Labs Inc.
90 - Change in the nature of ownership
|
+4,809,931 vol |
12,201,049 | |
| Filed 2024-03-12 10:20 Tx date 2018-11-30 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
LLC Units convertible into SV Shares Cresco Labs Inc.
00 - Opening Balance-Initial SEDI Report
|
8,356,118 | ||
| Filed 2024-03-12 10:18 Tx date 2020-09-02 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Holder: RMS Med Group, LLC (Control or Direction)
|
LLC Units convertible into SV Shares Cresco Labs Inc.
90 - Change in the nature of ownership
|
-9,081,214 vol |
0 | |
| Filed 2024-03-12 10:17 Tx date 2018-11-30 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Holder: RMS Med Group, LLC (Control or Direction)
|
LLC Units convertible into SV Shares Cresco Labs Inc.
00 - Opening Balance-Initial SEDI Report
|
9,081,214 | ||
| Filed 2023-09-19 17:31 Tx date 2020-09-02 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
LLC Units convertible into SV Shares Cresco Labs Inc.
90 - Change in the nature of ownership
|
+1,257,094 vol |
||
| Filed 2023-09-19 17:26 Tx date 2020-09-02 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Holder: RMS Med Group, LLC (Control or Direction)
|
LLC Units convertible into SV Shares Cresco Labs Inc.
90 - Change in the nature of ownership
|
-9,217,920 vol |
||
| Filed 2018-12-10 22:57 Tx date 2018-11-30 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Holder: RMS Med Group, LLC (Control or Direction)
|
LLC Units convertible into SV Shares Cresco Labs Inc.
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-12-10 22:56 Tx date 2018-11-30 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
LLC Units convertible into SV Shares Cresco Labs Inc.
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-02-12 19:08 Tx date 2024-02-09 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Super Voting Shares
11 - Acquisition or disposition carried out privately
|
+33,308 vol |
133,308 | |
| Filed 2024-01-17 19:57 Tx date 2023-12-12 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-46,442.30
-28,900 vol $1.61 each |
874,431 | |
| Filed 2024-01-17 19:56 Tx date 2023-12-11 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-141,801.52
-80,900 vol $1.75 each |
903,331 | |
| Filed 2023-09-19 17:34 Tx date 2023-09-07 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
-100,000 vol |
984,231 | |
| Filed 2023-09-19 17:33 Tx date 2023-05-05 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
36 - Conversion or exchange
|
+1,000,000 vol |
1,084,231 | |
| Filed 2023-09-19 17:31 Tx date 2023-05-05 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
LLC Units convertible into SV Shares Cresco Labs Inc.
36 - Conversion or exchange
|
-1,000,000 vol |
6,411,506 | |
| Filed 2023-09-19 17:31 Tx date 2020-09-02 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
LLC Units convertible into SV Shares Cresco Labs Inc.
90 - Change in the nature of ownership
|
+1,257,094 vol |
8,511,506 | |
| Filed 2023-09-19 17:26 Tx date 2020-09-02 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Holder: RMS Med Group, LLC (Control or Direction)
|
LLC Units convertible into SV Shares Cresco Labs Inc.
90 - Change in the nature of ownership
|
-9,217,920 vol |
0 | |
| Filed 2023-07-26 16:00 Tx date 2023-06-30 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+139,751 vol |
247,842 | |
| Filed 2022-12-15 14:44 Tx date 2022-10-26 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+20,000 vol |
108,091 | |
| Filed 2022-12-08 15:07 Tx date 2022-12-05 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-411,320
-100,000 vol $4.11 each |
84,231 | |
| Filed 2022-12-08 15:06 Tx date 2022-12-02 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-180,160
-50,000 vol $3.60 each |
184,231 | |
| Filed 2022-12-02 11:05 Tx date 2022-12-01 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-183,646.28
-52,400 vol $3.50 each |
234,231 | |
| Filed 2022-12-02 11:01 Tx date 2022-11-29 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-43,327.41
-13,300 vol $3.26 each |
286,631 | |
| Filed 2022-12-02 11:00 Tx date 2022-11-29 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-118,908
-36,700 vol $3.24 each |
299,931 | |
| Filed 2022-12-02 10:58 Tx date 2022-11-29 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-754,434.96
-232,800 vol $3.24 each |
336,631 | |
| Filed 2022-12-02 10:55 Tx date 2022-11-17 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-166,690.44
-47,600 vol $3.50 each |
569,431 | |
| Filed 2022-08-22 11:33 Tx date 2022-08-17 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
51 - Exercise of options
|
+417,031 vol |
617,031 | |
| Filed 2022-08-22 11:32 Tx date 2022-08-17 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-600,000 vol |
79,359 | |
| Filed 2022-08-22 11:31 Tx date 2018-11-30 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
600,000 | ||
| Filed 2020-05-25 17:19 Tx date 2018-11-30 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-07-21 16:00 Tx date 2022-07-15 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+68,389 vol |
88,091 | |
| Filed 2021-07-05 13:54 Tx date 2021-06-30 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+19,702 vol |
19,702 | |
| Filed 2021-07-05 13:54 Tx date 2018-11-30 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-21 15:20 Tx date 2021-06-18 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
11 - Acquisition or disposition carried out privately
|
$-12,500,000
-1,000,000 vol $12.50 each |
200,000 | |
| Filed 2021-06-09 12:45 Tx date 2021-06-01 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
36 - Conversion or exchange
|
+1,100,000 vol |
1,200,000 | |
| Filed 2021-06-09 12:44 Tx date 2021-06-01 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
LLC Units convertible into SV Shares Cresco Labs Inc.
36 - Conversion or exchange
|
-1,100,000 vol |
6,154,412 | |
| Filed 2020-12-21 12:17 Tx date 2020-12-16 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+24,534 vol |
79,359 | |
| Filed 2020-12-07 19:21 Tx date 2020-12-07 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
10 - Acquisition or disposition in the public market
|
$-8,190,000
-650,000 vol $12.60 each |
100,000 | |
| Filed 2020-12-07 19:21 Tx date 2020-08-24 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
36 - Conversion or exchange
|
+750,000 vol |
750,000 | |
| Filed 2020-12-07 19:20 Tx date 2018-11-30 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Subordinate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-12-07 19:20 Tx date 2020-08-24 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
LLC Units convertible into SV Shares Cresco Labs Inc.
36 - Conversion or exchange
|
-750,000 vol |
7,254,412 | |
| Filed 2020-05-25 17:21 Tx date 2020-05-20 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$250,001
+54,825 vol $4.56 each |
54,825 | |
| Filed 2020-05-25 17:19 Tx date 2018-11-30 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-30 19:26 Tx date 2019-07-25 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
LLC Units convertible into SV Shares Cresco Labs Inc.
11 - Acquisition or disposition carried out privately
|
$-2,257,500
-215,000 vol $10.50 each |
8,004,412 | |
| Filed 2018-12-10 Tx date 2018-11-30 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Super Voting Shares
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2018-12-10 Tx date 2018-11-30 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Holder: RMS Med Group, LLC (Control or Direction)
|
LLC Units convertible into SV Shares Cresco Labs Inc.
00 - Opening Balance-Initial SEDI Report
|
9,217,920 | ||
| Filed 2018-12-10 Tx date 2018-11-30 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
Proportionate Voting Shares
00 - Opening Balance-Initial SEDI Report
|
4 | ||
| Filed 2018-12-10 Tx date 2018-11-30 |
$CL
Cresco Labs Inc. |
Sampson, Robert Malcom
4 - Director of Issuer
Direct Ownership
|
LLC Units convertible into SV Shares Cresco Labs Inc.
00 - Opening Balance-Initial SEDI Report
|
8,219,412 |